-+ 0.00%
-+ 0.00%
-+ 0.00%

Asia Pacific Pharmaceutical announced that Zhejiang Yatai Lizhong Holdings Co., Ltd., a wholly-owned subsidiary of the company, plans to use 10 million yuan as a limited partner to jointly fund the establishment of the Hangzhou Qizhen Zhikang Equity Investment Partnership with various parties. The total pledge of the fund is 26.5 million yuan. The executive partner is Beijing Zheshang Huaying Venture Capital Management Co., Ltd. Recently, the fund has been registered with the China Securities Investment Fund Industry Association. The filing date is September 11, 2026. The filing code is SEM738, and the custodian is Bank of Ningbo Co., Ltd.

Zhitongcaijing·09/14/2026 08:17:09
Listen to the news
Asia Pacific Pharmaceutical announced that Zhejiang Yatai Lizhong Holdings Co., Ltd., a wholly-owned subsidiary of the company, plans to use 10 million yuan as a limited partner to jointly fund the establishment of the Hangzhou Qizhen Zhikang Equity Investment Partnership with various parties. The total pledge of the fund is 26.5 million yuan. The executive partner is Beijing Zheshang Huaying Venture Capital Management Co., Ltd. Recently, the fund has been registered with the China Securities Investment Fund Industry Association. The filing date is September 11, 2026. The filing code is SEM738, and the custodian is Bank of Ningbo Co., Ltd.